Clinical Trial

Quantifying Hepatic Mitochondrial Fluxes in Humans

Name: Quantifying Hepatic Mitochondrial Fluxes in Humans — clinical trial record (NCT05305287)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

In this study the investigators will quantitate hepatic mitochondrial fluxes in T2D patients with NAFL and NASH before and after 16-weeks treatment with the insulin sensitizer pioglitazone

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2022-03-22; most recent amendment 2026-01-07.

Trial Details

NCT Number	NCT05305287
Lead Sponsor	The University of Texas Health Science Center at San Antonio Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions	Non-Alcoholic Fatty Liver Disease, Type 2 Diabetes, Mitochondrial Metabolism Disorders
Enrollment	60 participants
Start Date	2022-11-01
Primary Completion	2027-03-31 (estimated)
Study Completion	2027-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-09